BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer
BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Background
Mutations in
BRCA1
and
BRCA2
are associated with better survival in ovarian cancer (OC) patients due to a better response to platinum-based chemotherapy. However, the impact of the
BRCA1/2
mRNA-expression is not well characterized in OC.
Patients and methods
We investigated
BRCA1/2
mRNA-expression in 12 n...
Alternative Titles
Full title
BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6173779
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6173779
Other Identifiers
ISSN
0007-0920
E-ISSN
1532-1827
DOI
10.1038/s41416-018-0217-4
